Optimal care for patients with irritable bowel syndrome (IBS) and chronic idiopathic constipation (CIC) includes timely and accurate diagnosis, early initiation of therapies and effective communication.
In this animated on-demand activity, Dr. Brooks D. Cash, from the University of Texas Health Science Center at Houston, shares guideline-based strategies to confirm a diagnosis of IBS-D, IBS-C or CIC, highlighting critical differential diagnoses to rule out and alarm features that warrant further investigation.
The program, An Exploration of Advances in the Diagnosis and Management of Irritable Bowel Syndrome and Chronic Idiopathic Constipation, also features expert insights into the clinical use and mechanism of action of newer/novel treatment options to provide the latest clinical findings on current over-the-counter and prescription treatments for IBS-C, IBS-D and CIC. Don’t miss this opportunity to learn from Dr. Cash and an actual IBS patient — and download point-of-care tools!
This program will help you:
- Integrate appropriate, validated testing measures to make definitive, timely diagnoses of IBS/CIC.
- Treat IBS/CIC in accordance with current evidence and guidelines, recognizing the appropriate use of new and emerging therapeutic agents.
- Implement strategies to establish effective communication and help patients with IBS/CIC increase participation in their care.
This activity is supported by an independent educational grant from AbbVie and Ironwood Pharmaceuticals.